Zinzino Overview
- Founded
-
2005
- Status
-
Public
- Employees
-
229
- Stock Symbol
-
ZZ B
- Investments
-
7
- Share Price
-
$2.66
- (As of Tuesday Closing)
Zinzino General Information
Description
Zinzino Holding AB is a direct sales company. The company offers products focusing on nutritional supplements, skincare, and lifestyle products. The company operates in two segments Zinzino and Faun. The majority of the revenue is generated from the Zinzino segment. The company's product areas include Immune and Brain, SkinCare, Weight Control, Beverages, and others. The company's geographical segments include Sweden, Hungary, Germany, Norway, Finland, Denmark, and other countries.
Contact Information
Primary Industry
Beverages
Other Industries
Food Products
Stock Exchange
STO
Primary Office
- Hulda Mellgrens gata 8
- Västra Frölunda
- 421 31 Gothenburg
- Sweden
+46 031-771 00 00
Zinzino Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.66 | $2.68 | $2.11 - $5.40 | $93.3M | 33.9M | 17K | $0.16 |
Zinzino Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 68,434 | 197,154 | 297,998 | 79,902 |
| Revenue | 137,646 | 150,035 | 116,531 | 75,148 |
| EBITDA | 10,104 | 16,019 | 11,771 | 3,545 |
| Net Income | 5,568 | 10,038 | 6,993 | 1,127 |
| Total Assets | 59,393 | 66,875 | 58,928 | 32,798 |
| Total Debt | 5,073 | 4,302 | 5,380 | 4,686 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Zinzino Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Zinzino Patents
Zinzino Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2014333878-A2 | Edible lipid composition comprising stearidonic acid and olive oil | Active | 07-Oct-2013 | 000000000 | |
| AU-2014333878-A1 | Edible lipid composition comprising stearidonic acid and olive oil | Active | 07-Oct-2013 | 000000000 | |
| AU-2014333878-B2 | Edible lipid composition comprising stearidonic acid and olive oil | Active | 07-Oct-2013 | 000000000 | |
| CA-2924265-A1 | Edible lipid composition comprising stearidonic acid and olive oil | Active | 07-Oct-2013 | 000000000 | |
| CA-2924265-C | Edible lipid composition comprising stearidonic acid and olive oil | Active | 07-Oct-2013 | A23D9/007 |
Zinzino Executive Team (7)
Zinzino Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ingela Nordenhav | Zinzino | Board Member | 000 0000 |
| Staffan Hillberg | Self | Board Member | 000 0000 |
Zinzino Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Zinzino Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Zinzino Investments & Acquisitions (7)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 | 05-Apr-2022 | 0000000000 | 00.000 | Personal Products | 000 00000 |
| 0000000 | 01-Jul-2020 | 0000000000 | 00.000 | Personal Products | 000 00000 |
| 0000 000000 | 06-Mar-2015 | 000000000 | 00000 | Other Consumer Non-Durables | 000 00000 |
| 000000000 000 | 08-Dec-2014 | 0000000000 | 00.000 | Food Products | |
| Faun Pharma | 28-Oct-2014 | Merger/Acquisition | 00.000 | Other Consumer Non-Durables | 000 00000 |
Zinzino Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| VMALife | Personal Products | Singapore, Singapore | 2015 |
| 0000 000000 | Other Consumer Non-Durables | Vestby, Norway | 0000 |
Zinzino ESG
Risk Overview
Risk Rating
Updated December, 07, 2022
12.84 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,613
Rank
0.00
Percentile
Retailing
Industry
00 of 485
Rank
00.00
Percentile
Distribution
Subindustry
00 of 32
Rank
00.00
Percentile
